Back to calendar
Braveheart Bio, Inc. (BRVE) Earnings
BRVE reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $2.69
Actual EPS: $-1.21
Company overview
Market Cap$2.0B
PriceUSD 26.71
52-week high32.00
52-week low24.30
SectorHealth Technology
IndustryPharmaceuticals: Major